Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists

Céline Audibert,1 Anna Perlaky,2 Mark Stuntz,2 Daniel Glass2 1Deerfield Institute, Epalinges, Switzerland; 2Deerfield Institute, New York, NY, USA Background: Advanced ovarian cancer patients have a poor prognosis, mainly because the disease is diagnosed at a late stage. A number of the...

Full description

Bibliographic Details
Main Authors: Audibert C, Perlaky A, Stuntz M, Glass D
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/variability-in-the-therapeutic-management-of-advanced-ovarian-cancer-p-peer-reviewed-article-DDDT